Literature DB >> 7699156

Infection control and prevention strategies in the ICU.

A F Widmer1.   

Abstract

Although only 5-10% of all hospitalized patients are treated in ICUs, they account for approximately 25% of all nosocomial infections, and the incidence of nosocomial infections in ICUs is 5-10 times higher than that observed in general hospital wards. Systemic and respiratory infections are far more common than in general wards, and most epidemics originate in ICUs. Nosocomial infections are the primary focus of most infection control programmes because they are the cause of high mortality rates in ICUs. Effective programmes are usually based on the cooperation of the intensive care physician, the infectious disease specialist, the microbiologist and the clinical epidemiologist. The infectious disease specialist develops specific guidelines for the antimicrobial therapy of typical infections which minimize the selective pressure for microorganisms within the ICU. The microbiologist provides rapid and accurate diagnosis of the pathogens involved. The clinical epidemiologist identifies epidemics at early stages, using epidemiological tools and molecular typing methods, as well as summarizing trends of antimicrobial susceptibility patterns and setting standards for isolation practices. A simple and inexpensive way to reduce nosocomial infections in ICUs is to ensure that staff disinfect their hands after dealing with a patient. Intravascular devices, mechanical ventilation and urinary catheterization are major risk factors for nosocomial infections, and their use should be evaluated daily and discontinued as soon as clinically possible. Selective decontamination of the digestive tract and the use of standard immunoglobulin for prophylaxis are still controversial and need further investigation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7699156     DOI: 10.1007/bf01713976

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  27 in total

Review 1.  The First European Consensus Conference in Intensive Care Medicine: selective decontamination of the digestive tract in intensive care unit patients. The European Society of Intensive Care Medicine; The Société Réanimation de Langue Française.

Authors: 
Journal:  Infect Control Hosp Epidemiol       Date:  1992-10       Impact factor: 3.254

Review 2.  The crisis in antibiotic resistance.

Authors:  H C Neu
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

3.  Infection control in intensive care units: U.K. national survey.

Authors:  T J Inglis; L J Sproat; P M Hawkey; P Knappett
Journal:  Br J Anaesth       Date:  1992-02       Impact factor: 9.166

4.  The clinical impact of culturing central venous catheters. A prospective study.

Authors:  A F Widmer; M Nettleman; K Flint; R P Wenzel
Journal:  Arch Intern Med       Date:  1992-06

5.  Quantitative tip culture methods and the diagnosis of central venous catheter-related infections.

Authors:  I I Raad; M F Sabbagh; K H Rand; R J Sherertz
Journal:  Diagn Microbiol Infect Dis       Date:  1992-01       Impact factor: 2.803

6.  Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement.

Authors:  I Raad; W Costerton; U Sabharwal; M Sacilowski; E Anaissie; G P Bodey
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

7.  Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections.

Authors:  A F Widmer; R Frei; Z Rajacic; W Zimmerli
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

8.  Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis.

Authors:  J A Jernigan; B M Farr
Journal:  Ann Intern Med       Date:  1993-08-15       Impact factor: 25.391

9.  Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition.

Authors:  A Sitges-Serra; P Puig; J Liñares; J L Pérez; N Farreró; E Jaurrieta; J Garau
Journal:  JPEN J Parenter Enteral Nutr       Date:  1984 Nov-Dec       Impact factor: 4.016

10.  Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991.

Authors:  A L Panlilio; D H Culver; R P Gaynes; S Banerjee; T S Henderson; J S Tolson; W J Martone
Journal:  Infect Control Hosp Epidemiol       Date:  1992-10       Impact factor: 3.254

View more
  5 in total

Review 1.  Antibacterial treatment of invasive mechanical ventilation-associated pneumonia.

Authors:  F Barcenilla; E Gascó; J Rello; L Alvarez-Rocha
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 2.  Immunotherapy in the management of sepsis.

Authors:  E A Fagan; M Singer
Journal:  Postgrad Med J       Date:  1995-02       Impact factor: 2.401

Review 3.  Sepsis: clinical dilemmas.

Authors:  M J Murray
Journal:  Yale J Biol Med       Date:  1998 Nov-Dec

4.  Facilities for Centralized Isolation and Quarantine for the Observation and Treatment of Patients with COVID-19: Experience from Wuhan, China.

Authors:  Xianliang Wang; Jiao Wang; Jin Shen; John S Ji; Lijun Pan; Hang Liu; Kangfeng Zhao; Li Li; Bo Ying; Lin Fan; Liubo Zhang; Lin Wang; Xiaoming Shi
Journal:  Engineering (Beijing)       Date:  2021-04-22       Impact factor: 7.553

5.  Prevention of nosocomial infections in critically ill patients with lactoferrin (PREVAIL study): study protocol for a randomized controlled trial.

Authors:  John Muscedere; David Maslove; John Gordon Boyd; Nicole O'Callaghan; Francois Lamontagne; Steven Reynolds; Martin Albert; Rick Hall; Danielle McGolrick; Xuran Jiang; Andrew G Day
Journal:  Trials       Date:  2016-09-29       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.